LEMAITRE VASCULAR, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
LEMAITRE VASCULAR, INC. (LMAT) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $0 as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-02-26
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.36M.
- 2024-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.29M.
- 2024-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.27M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $1.36M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.29M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.27M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.25M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.22M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.28M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $1.38M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $1.36M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $1.34M 10-K · filed 2026-02-26 |
| 2022-09-30 | $1.53M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $1.52M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $1.51M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $1.49M 10-K · filed 2025-02-28 |
| 2021-09-30 | $1.73M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $2.30M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $2.27M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $2.24M 10-K · filed 2024-02-29 |
| 2020-09-30 | $2.21M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $2.23M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $1.79M 10-Q · filed 2021-05-10 |
| 2019-12-31 | $1.76M 10-K · filed 2023-03-01 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2019-03-31 | $26.00K 10-Q · filed 2020-05-08 |
| 2018-12-31 | $72.00K 10-K · filed 2022-02-28 |
| 2018-09-30 | $106.00K 10-Q · filed 2019-11-08 |
| 2018-06-30 | $200.00K 10-Q · filed 2019-08-06 |
| 2018-03-31 | $1.29M 10-Q · filed 2019-05-06 |
| 2017-12-31 | $1.30M 10-K · filed 2021-03-12 |
| 2017-09-30 | $1.30M 10-Q · filed 2018-11-02 |
| 2017-06-30 | $1.30M 10-Q · filed 2018-08-06 |
| 2017-03-31 | $1.32M 10-Q · filed 2018-05-04 |
| 2016-12-31 | $1.32M 10-K · filed 2020-03-12 |
| 2014-09-30 | $237.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $328.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $99.00K 10-Q · filed 2014-08-07 |
| 2013-12-31 | $99.00K 10-K · filed 2017-03-09 |
| 2013-09-30 | $35.00K 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |